1-9 of 9
Alessandra Petrelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1554-P: Phenotype and Clonality of Fat-Derived CD8 T Cells in Patients with Type 1 Diabetes

Free
ALESSANDRA PETRELLI, NICOLA BALDONI, ANNA GIOVENZANA, VALENTINA CODAZZI, FRANCESCA ALEOTTI, VALENTINA TOMAJER, GIOVANNI CESANA, STEFANO OLMI, MASSIMO FALCONI, LORENZO PIEMONTI, PAOLO FIORINA
Journal: Diabetes
Diabetes 2024;74(Supplement_1):1554-P
https://doi.org/10.2337/db25-1554-P
Published: 20 June 2025
View articletitled, 1554-P: Phenotype and Clonality of Fat-Derived CD8 T Cells in Patients with Type 1 Diabetes
Meeting Abstracts

1962-LB: Baseline Insulin Secretion Determines the Response to Abatacept In Stage 1 Type 1 Diabetes

Free
ALICE L.J. CARR, ALFONSO GALDERISI, PETER TAYLOR, JACOPO BONET, DAVID D. CUTHBERTSON, JAY SOSENKO, EMILY K. SIMS, CARMELLA EVANS-MOLINA, CHIARA DALLA MAN, PETER A. SENIOR, HEBA M. ISMAIL, BRANDON M. NATHAN, ALESSANDRA PETRELLI, JENNIFER L. SHERR, KEVAN C. HEROLD, WILLIAM E. RUSSELL, ANTOINETTE MORAN, COLIN DAYAN
Journal: Diabetes
Diabetes 2024;74(Supplement_1):1962-LB
https://doi.org/10.2337/db25-1962-LB
Published: 20 June 2025
View articletitled, 1962-LB: Baseline Insulin Secretion Determines the Response to Abatacept In Stage 1 Type 1 Diabetes
Meeting Abstracts

719-P: Oral Disposition Index (oDI) as an Outcome Measure in Type 1 Diabetes (T1D) Clinical Trials—Evidence from Stage 1 and Stage 2 Trials

Free
ALFONSO GALDERISI, DAVID D. CUTHBERTSON, ALESSANDRA PETRELLI, ANTOINETTE MORAN, JAY SOSENKO, LAURA M. JACOBSEN, INGRID LIBMAN, MARIA J. REDONDO, HEBA M. ISMAIL
Journal: Diabetes
Diabetes 2024;74(Supplement_1):719-P
https://doi.org/10.2337/db25-719-P
Published: 20 June 2025
View articletitled, 719-P: Oral Disposition Index (oDI) as an Outcome Measure in Type 1 Diabetes (T1D) Clinical Trials—Evidence from Stage 1 and Stage 2 Trials
Journal Articles

The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes

Free
Heba M. Ismail, David Cuthbertson, Alfonso Galderisi, Ingrid Libman, Laura Jacobsen, Antoinette Moran, Alessandra Petrelli, Mark Atkinson, Maria J. Redondo, Tamara Hannon, Kieren J. Mather, Jay M. Sosenko
Journal: Diabetes
Diabetes 2025;74(7):1196–1204
https://doi.org/10.2337/db24-1000
Published: 02 April 2025
View articletitled, The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes
Open the PDF for The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes in another window
Journal Articles

Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes

Free
Alessandra Petrelli, Mark A. Atkinson, Massimo Pietropaolo, Nick Giannoukakis
Journal: Diabetes
Diabetes 2021;70(2):313–322
https://doi.org/10.2337/dbi20-0026
Published: 14 January 2021
View articletitled, Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes
Open the PDF for Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes in another window
Journal Articles

The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes

Open Access
Jamil Azzi, Robert F. Moore, Wassim Elyaman, Marwan Mounayar, Najib El Haddad, Sunmi Yang, Mollie Jurewicz, Ayumi Takakura, Alessandra Petrelli, Paolo Fiorina, Thomas Ruckle, Reza Abdi
Journal: Diabetes
Diabetes 2012;61(6):1509–1518
https://doi.org/10.2337/db11-0134
Published: 14 May 2012
View articletitled, The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes
Open the PDF for The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes in another window
Includes: Supplementary data
Journal Articles

Inotuzumab Ozogamicin Murine Analog–Mediated B-Cell Depletion Reduces Anti-islet Allo- and Autoimmune Responses

Open Access
Michele Carvello, Alessandra Petrelli, Andrea Vergani, Kang Mi Lee, Sara Tezza, Melissa Chin, Elena Orsenigo, Carlo Staudacher, Antonio Secchi, Kyri Dunussi-Joannopoulos, Mohamed H. Sayegh, James F. Markmann, Paolo Fiorina
Journal: Diabetes
Diabetes 2012;61(1):155–165
https://doi.org/10.2337/db11-0684
Published: 12 December 2011
View articletitled, Inotuzumab Ozogamicin Murine Analog–Mediated B-Cell Depletion Reduces Anti-islet Allo- and Autoimmune Responses
Open the PDF for Inotuzumab Ozogamicin Murine Analog–Mediated B-Cell Depletion Reduces Anti-islet Allo- and Autoimmune Responses in another window
Journal Articles

IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response

Open Access
Alessandra Petrelli, Michele Carvello, Andrea Vergani, Kang Mi Lee, Sara Tezza, Ming Du, Sonja Kleffel, Liu Chengwen, Bechara G. Mfarrej, Patrick Hwu, Antonio Secchi, Warren J. Leonard, Deborah Young, Mohamed H. Sayegh, James F. Markmann, Allan J. Zajac, Paolo Fiorina
Journal: Diabetes
Diabetes 2011;60(12):3223–3234
https://doi.org/10.2337/db11-0880
Published: 13 November 2011
View articletitled, IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response
Open the PDF for IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response in another window
Includes: Supplementary data
Journal Articles

A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice

Open Access
Andrea Vergani, Francesca D'Addio, Mollie Jurewicz, Alessandra Petrelli, Toshihiko Watanabe, Kaifeng Liu, Kenneth Law, Christian Schuetz, Michele Carvello, Elena Orsenigo, Shaoping Deng, Scott J. Rodig, Javeed M. Ansari, Carlo Staudacher, Reza Abdi, John Williams, James Markmann, Mark Atkinson, Mohamed H. Sayegh, Paolo Fiorina
Journal: Diabetes
Diabetes 2010;59(9):2253–2264
https://doi.org/10.2337/db09-1264
Published: 01 September 2010
View articletitled, A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice
Open the PDF for A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice in another window